Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function

被引：0
|
作者：
Jeong Eun Kim
Baek-Yeol Ryoo
Yoon-Koo Kang
机构：
[1] University of Ulsan College of Medicine,Department of Oncology, Asan Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Sorafenib; Future Clinical Trial; Lower Efficacy; Antitumor Efficacy; Liver Function Deterioration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1641 / 1642
页数：1
相关论文
共 50 条
  • [41] Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver Cirrhosis
    Roberto Santambrogio
    Enrico Opocher
    Massimo Zuin
    Carlo Selmi
    Emanuela Bertolini
    Mara Costa
    Matteo Conti
    Marco Montorsi
    Annals of Surgical Oncology, 2009, 16 : 3289 - 3298
  • [42] The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis
    Chiu, Joanne
    Tang, Yuen Fong
    Yao, Tzy-Jyun
    Wong, Ashley
    Wong, Hilda
    Leung, Roland
    Chan, Pierre
    Cheung, Tan To
    Chan, Albert C.
    Pang, Roberta
    Fan, Sheung-Tat
    Poon, Ronnie
    Yau, Thomas
    CANCER, 2012, 118 (21) : 5293 - 5301
  • [43] OUTCOME OF PATIENTS WITH CHILD-PUGH C LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
    Sieghart, W.
    Pinter, M.
    Graziadei, I.
    Hucke, F.
    Rasoul-Rockenschaub, S.
    Stauber, R.
    Wagner, D.
    Vogel, W.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S265 - S265
  • [44] Indication of Hepatectomy for Cirrhotic Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B
    Hideki Nakahara
    Toshiyuki Itamoto
    Koji Katayama
    Hideki Ohdan
    Hiroshi Hino
    Makoto Ochi
    Hirotaka Tashiro
    Toshimasa Asahara
    World Journal of Surgery, 2005, 29 : 734 - 738
  • [45] Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Saito, Tomoko
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Kanai, Fumihiko
    Yokosuka, Osamu
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (03) : 729 - 739
  • [46] Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis
    Chapin, William J.
    Hwang, Wei-Ting
    Karasic, Thomas B.
    McCarthy, Anne Marie
    Kaplan, David E.
    CANCER MEDICINE, 2023, 12 (01): : 189 - 199
  • [47] Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B
    Nakahara, H
    Itamoto, T
    Katayama, K
    Ohdan, H
    Hino, H
    Ochi, M
    Tashiro, H
    Asahara, T
    WORLD JOURNAL OF SURGERY, 2005, 29 (06) : 734 - 738
  • [48] Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B
    Shintaro Kuroda
    Hirotaka Tashiro
    Tsuyoshi Kobayashi
    Akihiko Oshita
    Hironobu Amano
    Hideki Ohdan
    World Journal of Surgery, 2011, 35 : 834 - 841
  • [49] IGF-Child-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.
    Abugabal, Yehia I.
    Hassan, Manal
    Xiao, Lianchun
    Morris, Jeffrey
    Pestana, Roberto Carmagnani
    Abdel-Wahab, Reham
    Hatia, Rikita
    Chang, Ping
    Girard, Lauren
    Rashid, Asif
    Bhawana, George
    Raghav, Kanwal Pratap Singh
    Abdelhakeem, Ahmed
    Wolff, Robert A.
    Amin, Hesham M.
    Kaseb, Ahmed Omar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [50] ALBI GRADE VS. CHILD-PUGH GRADE AS A GRADING SYSTEM FOR LIVER FUNCTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Jung, Y. K.
    Na, S. K.
    Suh, S. J.
    Yim, H. J.
    Kim, S. Y.
    Hyun, J. J.
    Jung, S. W.
    Koo, J. S.
    Kim, J. H.
    Seo, Y. S.
    Yeon, J. E.
    Lee, S. W.
    Byun, K. S.
    Um, S. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S343 - S344
12345